nirsevimab
Jump to navigation
Jump to search
English
[edit]
Etymology
[edit][Term?] + -vi- + -mab (This etymology is missing or incomplete. Please add to it, or discuss it at the Etymology scriptorium.)
Noun
[edit]nirsevimab (uncountable)
- (pharmacology) A human recombinant monoclonal antibody used to prevent respiratory syncytial virus (RSV) infections in infants.
- 2023 May 18, Christina Jewett, “F.D.A. Panel Recommends R.S.V. Vaccine to Protect Young Infants”, in The New York Times[1]:
- There is another remedy under regulatory consideration, a monoclonal antibody shot developed by Sanofi and AstraZeneca, called nirsevimab. It is meant to be given at the hospital to babies who are born during the winter or in the fall, Jonathan Heinrichs, a Sanofi executive said in an interview.